Giovanni Docimo

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

R. Marfella, T. Salvatore, F. C. Sasso, 2022, International journal of molecular sciences.

Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes

Christian Catalini, R. Marfella, T. Salvatore, 2022, International journal of molecular sciences.

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

R. Torella, R. Marfella, L. Zirpoli, 2022, Cardiovascular Diabetology.

"TIME" FOR OBESITY-RELATED CANCER: THE ROLE OF THE CIRCADIAN RHYTHM IN CANCER PATHOGENESIS AND TREATMENT.

G. Muscogiuri, A. Colao, L. Barrea, 2023, Seminars in cancer biology.

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options

R. Marfella, T. Salvatore, F. C. Sasso, 2023, International journal of molecular sciences.

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database

G. Paolisso, A. De Angelis, F. Rossi, 2023, Biomedicines.

Parathyroid Retrospective Analysis of Neoplasms Incidence (pTRANI Study): An Italian Multicenter Study on Parathyroid Carcinoma and Atypical Parathyroid Tumour

F. Cianchi, G. Perigli, C. Lombardi, 2023, Journal of clinical medicine.

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

C. Scavone, M. R. Campitiello, Giovanni Docimo, 2023, Drugs - real world outcomes.

The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database

Alessia Zinzi, Mario Gaio, Giovanni Docimo, 2023, Biomedicines.